Riskpilot← Back to searchSign inGet full accessScandinavian Medical Solutions A/S
A/SActiveCVR 39901749Gasværksvej 48, 1. tvWholesale of pharmaceutical and medical goods · NACE 4646Est. 201830 employees
Revenue 2025
DKK 220,5M
-3% vs 2024
EBITDA margin
4.1%
-56% vs 2024
Equity ratio
40.8%
Financial strength
Net profit 2025
DKK 26K
-100% vs 2024
| Revenue | DKK 220,5M | -3% |
| EBITDA | DKK 9M | -56% |
| Net profit | DKK 26K | -100% |
| Total assets | DKK 202,4M | +16% |
| Equity | DKK 82,7M | +0% |
| Employees | 30 | — |
Legal name
Scandinavian Medical Solutions A/S
CVR number
39901749
Legal form
Aktieselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. oktober 2018
Share capital
DKK 1.112.240
Employees
30 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør i forening med 1 bestyrelsesmedlem eller af alle bestyrelsesmedlemmerne i forening.
Company purpose
Selskabets formål er køb, salg og udlejning af hospitalsudstyr og reservedele, samt at drive handel, industri, investering og finansiering.
Address
Gasværksvej 48, 1. tv
Email
accounting@scandinavian-medical.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 71.638 | 110.530 | 191.192 | 226.123 | 220.456 |
| Staff expenses | -2.983 | -7.329 | -13.648 | -17.220 | -19.539 |
| EBITDA | 10.898 | 15.350 | 21.082 | 20.314 | 9.030 |
| Depreciation & amort. | -24 | -609 | -4.455 | -7.159 | -8.000 |
| EBIT | 10.873 | 14.741 | 16.627 | 13.155 | 1.030 |
| Net financials | -333 | -29 | -833 | -3.156 | -1.076 |
| Profit before tax | 10.540 | 14.712 | 15.794 | 9.998 | -46 |
| Tax | 2.383 | 3.339 | 3.569 | 2.211 | -72 |
| Net profit | 8.157 | 11.373 | 12.224 | 7.787 | 26 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 44.644 | 106.125 | 163.964 | 174.027 | 202.365 |
| Equity | 24.110 | 62.186 | 74.451 | 82.483 | 82.665 |
| Long-term debt | 0 | 3.271 | 17.690 | 13.351 | 30.342 |
| Short-term debt | 20.535 | 40.331 | 71.823 | 77.247 | 87.533 |
| Total debt | 20.535 | 43.940 | 89.513 | 90.597 | 117.875 |
EBITDA margin
4.1%
This company
15.8%
Market median
-74% vs market
20212025
Equity ratio
40.8%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
1.09×
This company
1.12×
Market median
+3% vs market
20212025
Debt / equity
1.45×
This company
0.62×
Market median
-134% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
JH Chief Executive Officer | Chief Executive Officer | 2023 |
KP Management | Management | 2023 |
JK Management | Management | 2023 |
EM | Founder | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2026 | |
| Chairman | 2025 | |
| Board of Directors | 2021 | |
| Board of Directors | 2025 | |
| Former (3) | ||
| Deputy Chairman | 2021 – 2025 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2022 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25–33.32% | 25–33.32% | 2021 | |
| Company | 15–19.99% | 15–19.99% | 2021 | |
| Company | 5–9.99% | 5–9.99% | 2025 | |
| Company | 50–66.65% | 50–66.65% | 2019 | |
| Company | 5–9.99% | 5–9.99% | 2021 | |
| Company | 5–9.99% | 5–9.99% | 2021 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
J. Krohn Holding ApS
Scandinavian Medical Solutions A/S Board members of Scandinavian Medical Solutions A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jens Hvid Paulsen | Chief Executive Officer | 0 companies |
| Kamilla Pia Malmbæk | Management | 0 companies |
| Jens Krohn | Management | 0 companies |
| Elite Medical Technologies LLC | Founder | 0 companies |
| Anne Bülow Kaptain | Deputy Chairman | 0 companies |
| Henrik Ostenfeld Larsen | Board of Directors | 0 companies |
| Jonas Wulff Møller | Chairman | 0 companies |
| Morten Rasmussen | Board of Directors | 0 companies |
| Mille Tram Lux | Chairman | 0 companies |
| Jakob Alsted Have | Board of Directors | 0 companies |
| Lene Gram Skjoldager | Board of Directors | 0 companies |